How Medical Cannabis May Support Anxiety Symptoms in Complex Disorders
Cannabis anxiety clinical updates highlight emerging evidence on how medical cannabis may support anxiety symptoms. Anxiety disorders are complex, and cannabinoid therapy shows variable patient responses. Understanding these updates helps guide safer,…
Endocannabinoid System: Cannabis Anxiety Research 2026
Endocannabinoid system cannabis anxiety research shows that cannabis use produces measurable reductions in anxiety symptoms. CBD-containing products demonstrated anxiolytic effects, while THC's role varied by product type. Understanding these differences…
Medical Marijuana Should Not Be Recommended for PTSD, Anxiety, or Depression
Cannabis use disorder schizophrenia risk is a critical concern for patients with PTSD, anxiety, or depression. Current evidence shows significant psychiatric risks including schizophrenia development in vulnerable populations. Clinicians should…
Will Medicinal Cannabis Help My Mental Health? Evidence and Risks
Medicinal cannabis demand for mental health soars despite limited clinical evidence. Patients report benefits for anxiety and PTSD, but risks remain significant. Clinicians emphasize careful risk assessment and monitoring.
Mental Health Problems More Likely for Teen Cannabis Users
Adolescent cannabis mental health studies show increased psychiatric risks for teen cannabis users. These studies highlight the vulnerability of the developing brain to cannabis exposure. Clinicians should screen for cannabis use alongside mental health…
Cannabis Pharmacokinetics Review: THC, CBD, Dosing
This paper is a broad evidence review of human pharmacokinetic studies on THC and CBD. It helps clarify how route, formulation, food, sex, drug interactions, and patient factors can meaningfully change absorption and exposure. Its main limitation is that…
Study: Clinical evidence review for Cannabidiol
This 2024 paper is a narrative review of cannabidiol, cannabis-derived products, regulation, pharmacology, and clinical use. It offers a useful overview of why purified CBD, commercial extracts, and broader cannabis products should not be treated as…
West-Asia War Impact: IDF Strikes and Psychological Stress
Military conflicts and psychological stress significantly impact mental health, especially PTSD and anxiety. Cannabis medicine may help manage acute stress responses during such events. Understanding this relationship is crucial for vulnerable…
Cannabidiol in Anorexia Nervosa: A Double-Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change.
This pilot study evaluates cbd anorexia nervosa safety in a randomized, placebo-controlled trial. It focuses on tolerability and pharmacokinetics in affected women. The findings provide preliminary safety data for future research.
Cannabis Products Policy and Regulation Insights 2026
This article reviews cannabis products policy and regulation amid evolving 2026 wellness markets. It highlights the clinical evidence gap and consumer misinformation challenges. Clinicians must navigate these complexities carefully.
